FIIs increase stake in Dr Reddy’s Lab during March quarter

21 Apr 2014 Evaluate

Foreign Institutional Investors (FIIs) have raised their stake in Dr Reddy’s Laboratories, an integrated global pharmaceutical company to 34.30% at the end of March 2014 quarter from 33.35% as on December 31, 2013.

On the other hand, domestic institutional investors’ (DIIs) shareholding has decreased to 6.29% at the end of March 2014 quarter from 7.54% as on December 31, 2013. Under DIIs, mutual funds / UTI held maximum stake of 4.89%, followed by insurance companies (1.34 % stake) and Financial Institutions / Banks (0.06 stake).

Meanwhile, promoter and promoter group shareholding was unchanged at 25.52% at the end of March 2014 quarter.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1253.60 -17.45 (-1.37%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×